Olympus to Acquire BioProtect for $270 Million

Blackstone and TPG Acquire Hologic in $18.3B Take-Private

October 22, 2025

Medical Devices

Hologic agreed to be acquired by funds managed by Blackstone and TPG in a transaction valued at up to $79 per share and approximately $18.3 billion enterprise value. The deal provides $76 per share in cash plus a non-tradable contingent value right (CVR) worth up to $3 per share tied to Breast Health revenue milestones in fiscal 2026 and 2027.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

Johnson & Johnson to Acquire Proteologix, Inc.

May 16, 2024

Biotechnology

Johnson & Johnson entered into a definitive agreement to acquire privately held biotechnology company Proteologix for $850 million in cash, with potential additional milestone payments. The deal is expected to close mid-year 2024 subject to antitrust clearance and customary closing conditions, expanding J&J’s bispecific antibody pipeline for immune-mediated diseases including atopic dermatitis and asthma.

Olympus to Acquire Odin Vision

December 20, 2022

Medical Devices

Olympus Corporation has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company, for up to GBP 66 million in upfront and milestone payments. The purchase is part of Olympus' broader digital strategy to integrate AI-driven detection, diagnostics, and cloud-enabled workflow solutions into its Digital Endosuite to improve clinical decision-making and patient outcomes.

Boston Scientific to Acquire Apollo Endosurgery for $615 Million

November 30, 2022

Medical Devices

Boston Scientific Corporation has entered into a definitive agreement to acquire Apollo Endosurgery for $615 million in cash (approximately $10 per share). The deal expands Boston Scientific’s endoluminal surgery (ELS) capabilities and adds an adjacency into the endobariatric market.

BMC Protect Acquires 360 Medical Supply

May 24, 2021

Healthcare Services

BMC Protect (formerly Bay Medical Company) acquired 360 Medical Supply, a specialty distributor of medical supplies serving the healthcare sector. The acquisition expands BMC Protect’s product offering and customer base and is intended to deepen penetration into the post-acute care market segment.